Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Global Pulmonary Embolism Market Report 2024 - Targeted Therapies Are Becoming Increasingly Personalized, Focusing on Patient-Specific Conditions and Genetic Profiles | ||
By: PR Newswire Association LLC. - 12 Feb 2024 | Back to overview list |
|
DUBLIN, Feb. 12, 2024 /PRNewswire/ -- The "Pulmonary Embolism Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The recent market research report reveals that the global pulmonary embolism market is expected to surge from $2.03 billion in 2024 to an impressive $3.2 billion by 2028, demonstrating a compound annual growth rate (CAGR) of 12.1%. This significant growth trajectory is attributed to advancements in targeted therapies, the rising use of telemedicine and remote monitoring, as well as various health equity and global health initiatives. With an increasing prevalence of blood clots and a corresponding heightened risk of pulmonary embolism, the demand for effective medical management and treatment solutions is on the rise. The incorporation of artificial intelligence in diagnosis, development of novel anticoagulants, establishment of pulmonary embolism response teams, and adoption of patient-centered care approaches are notable trends bolstering the market's growth prospects. The latest data indicates that North America remains the largest region in terms of pulmonary embolism market share as of 2023. However, Asia-Pacific is emerging as the fastest-growing region, signaling robust developmental opportunities and market penetration in these geographies. Market leaders and health entities are focusing on innovative product releases to stay competitive. Among such innovations are the Triever16 Curve catheter and the RevCore thrombectomy catheter, designed to enhance the safety and effectiveness of thrombectomy procedures. This market research report encompasses a comprehensive analysis of the pulmonary embolism market, providing insights into different treatment modalities, diagnosis methods, symptoms, distribution channels, and healthcare providers involved in the management of pulmonary embolism. It emphasizes the revenues generated by these market constituents, which include the sale of diagnostic imaging equipment, oxygen delivery devices, interventional devices, medical alert systems, and pulse oximeters. The Pulmonary Embolism Market: A Closer Look at Key Drivers
Challenges and Opportunities The comprehensive data assists in understanding the complexities of the market, shaping strategies that align with the current trends and future expectations. In conclusion, this research report serves as an invaluable asset, intricately detailing the pulmonary embolism market dynamics and forecasting the industry's course over the next several years. With the inclusion of various market forces and emerging trends, the report furnishes a strategic viewpoint to remain informed and ahead in the global pulmonary embolism market landscape. For an in-depth market perspective and a forecast of future scenarios, this report on pulmonary embolism market dynamics is an essential resource for anyone looking to understand the prevailing trends, challenges, and opportunities within the industry. Key Markets Covered:
Companies Profiled
For more information about this report visit https://www.researchandmarkets.com/r/q9opqy About ResearchAndMarkets.com Media Contact: Research and Markets For E.S.T Office Hours Call +1-917-300-0470 U.S. Fax: 646-607-1907 Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg SOURCE Research and Markets |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |